Quoin Pharmaceuticals, Ltd. (QNRX) › Shares OutstandingQuoin Pharmaceuticals, Ltd. (QNRX) — Shares OutstandingAnnual figures by period end, from SEC filings.2020-12-31: 1.20B2021-12-31: 3.35B2022-12-31: 403.9K2023-12-31: 987.2K2024-12-31: 8.95M2025-12-31: 52.44M52.44M2020-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3152.44M+486.1%2026-03-26Balance as of period end2024-12-318.95M+806.4%2026-03-26Balance as of period end2023-12-31987.2K+144.4%2025-03-13Balance as of period end2022-12-31403.9K-100.0%2024-03-14Balance as of period end2021-12-313.35B+179.2%2023-03-15Balance as of period end2020-12-311.20B—2022-04-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)